The number of people with susceptibility test result for rifampicin in Iran, Islamic Republic of
Iran, Islamic Republic of: The number of people with susceptibility test result for rifampicin was 1,828 in 2021. ▼ Falling
Latest (2021)
1,828
Change on year
up 31.8%
World rank
51st
of 155 countries
All-time high
3,185
in 2019
All-time low
1,387
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Iran, Islamic Republic of, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Iran, Islamic Republic of is 1,828, measured in 2021.
Compared with earlier readings it is up 31.8% on the previous year and down 39.8% over five years.
That places Iran, Islamic Republic of 51st out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Iran, Islamic Republic of, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 3,035 | — |
| 2018 | 2,805 | -7.6% |
| 2019 | 3,185 | +13.5% |
| 2020 | 1,387 | -56.5% |
| 2021 | 1,828 | +31.8% |
Iran, Islamic Republic of compared with similar countries
- Iran, Islamic Republic of's 1,828 is above the median for upper middle income countries, which is 880, 2.1× the median. (46 countries reporting)
- Iran, Islamic Republic of's 1,828 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 4.5× the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3,008 | 2,805 | 3,185 | 3 |
| 2020s | 1,608 | 1,387 | 1,828 | 2 |
Countries ranked near Iran, Islamic Republic of
- 48 Guinea-Bissau 1,934 compare
- 49 Kyrgyzstan 1,932 compare
- 50 Tajikistan 1,862 compare
- 52 Togo 1,805 compare
- 53 Chile 1,772 compare
- 54 United Kingdom of Great Britain and Northern Ireland 1,734 compare
More health data for Iran, Islamic Republic of
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0311 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Iran, Islamic Republic of?
- The number of people with susceptibility test result for rifampicin in Iran, Islamic Republic of was 1,828 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Iran, Islamic Republic of?
- The highest recorded value was 3,185 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Iran, Islamic Republic of?
- The lowest recorded value was 1,387 in 2020.
- How does Iran, Islamic Republic of rank for the number of people with susceptibility test result for rifampicin?
- Iran, Islamic Republic of ranks 51st out of 155 countries with data for 2021.
- Where does this Iran, Islamic Republic of data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).